NM
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Liquid Chromatography-Tandem Mass Spectrometry Method for Ticagrelor and its Active Metabolite Determination in Human Plasma: Application to a Pharmacokinetic Study | Current Analytical Chemistry | 2019 | 465 | 1 | |||
| Impact of Boosted Antiretroviral Therapy on the Pharmacokinetics and Efficacy of Clopidogrel and Prasugrel Active Metabolites | Clinical Pharmacokinetics | 2018 | 727 | 739 | |||
| Prediction of drug-drug interactions using physiologically-based pharmacokinetic models of CYP450 modulators included in Simcyp software | Biopharmaceutics & Drug Disposition | 2018 | 621 | 12 | |||
| Characterization of oxycodone in vitro metabolism by human cytochromes P450 and UDP-glucuronosyltransferases | Journal of pharmaceutical and biomedical analysis | 2017 | 659 | 695 | |||
| CYP450-mediated drug-drug interactions: towards prediction and informed dose recommendation using physiologically-based pharmacokinetic (PBPK) modeling | 2017 | 893 | 0 | ||||
| Why has model-informed precision dosing not yet become common clinical reality? lessons from the past and a roadmap for the future | Clinical Pharmacology and Therapeutics | 2017 | 592 | 0 | |||
| Usefulness of PBPK Modeling in Incorporation of Clinical Conditions in Personalized Medicine | Journal of Pharmaceutical Sciences | 2017 | 486 | 0 | |||
| Coadministration of ticagrelor and ritonavir: Toward prospective dose adjustment to maintain an optimal platelet inhibition using the PBPK approach | Clinical pharmacology and therapeutics | 2016 | 660 | 729 | |||
| Intestinal permeability and P-glycoprotein-mediated efflux transport of ticagrelor in Caco-2 monolayer cells | Fundamental & clinical pharmacology | 2016 | 619 | 21 | |||
| Prediction of Metabolic Interactions With Oxycodone via CYP2D6 and CYP3A Inhibition Using a Physiologically Based Pharmacokinetic Model | CPT: pharmacometrics & systems pharmacology | 2014 | 671 | 262 |
